Cite
HARVARD Citation
Askar, S. et al. (2023). Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection With a Focus on Immunocompromised Patients. Journal of pharmacy practice. pp. 584-587. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Askar, S. et al. (2023). Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection With a Focus on Immunocompromised Patients. Journal of pharmacy practice. pp. 584-587. [Online].